Endo International plc (NASDAQ: ENDP), a United States-based branded and generics pharmaceutical company, has named Christie Smith, PhD as its new non-executive director, effective 29 July 2020, it was reported on Wednesday.
Prior to joining Endo International plc, Dr Smith served as the global vice president for Inclusion and Diversity at Apple. She has also been appointed to Endo's Compensation and Nominating, and Governance Committees. She has held the position of interim head of human resources at Grail and has held various leadership roles within Deloitte, including regional managing partner and head of the human capital and life sciences practices. She was also a member of Deloitte's executive leadership team.
Dr Smith has a Bachelor of Arts degree from Loyola College in Baltimore, a Masters in Social Work from Rutgers University and a Doctorate from New York University.
Par Pharmaceutical starts shipping colchicine 0.6mg capsules
Padagis launces Brinzolamide Ophthalmic Suspension with CGT exclusivity
Novartis completes Sandoz Spin-off
Novartis completes Sandoz spin-off, focusing on innovative medicines
Hikma marks KLOXXADO two-year anniversary by surpassing 375,000 doses donated in the US
STADA seeks full approval for Kinpeygo in IgA nephropathy from UK MHRA
Azurity Pharmaceuticals completes Slayback Pharma acquisition
Sandoz secures European approval for Tyruko biosimilar in MS treatment
Senores Pharmaceuticals introduces Nicardipine Hydrochloride Capsules USP, 20mg and 30mg in US
Lupin collaborates with Mark Cuban Cost Plus Drug Company and COPD foundation
Certara Simcyp receives FDA grants for advanced pharmacokinetic modelling
Sandoz's Tyruko (natalizumab-sztn) gains FDA approval as first biosimilar for relapsing MS
Nephron Pharmaceutical names new chief procurement officer
Lupin Pharmaceuticals launches Tiotropium Bromide Inhalation Powder, 18mcg/capsule in US